Furthermore, to evaluate the clinical significance of urinary glycosylated OPN as a urolithiasis biomarker, we also conducted a prospective longitudinal follow-up of urinary glycosylated OPN normalized to urinary full-length OPN (uFL-OPN) levels during stone treatment by ureteroscopic lithotripsy (URS). Here, SPP1 is linked to urolithiasis.